A Hydroxytyrosol-Based Pharmaceutical Formulation for the Prevention of Cardiovascular Disease: A Randomized Controlled Crossover Trial

Autor: Trombetta Domenico, 1° Di Renzo Laura, 2°* Smeriglio Antonella, 1 Cascapera Stefano, 3, 4 Carmela Colica5

Publikováno v: Biomedicine & preventive nutrition (2017): 62–69.
info:cnr-pdr/source/autori:Trombetta Domenico,1° Di Renzo Laura,2°* Smeriglio Antonella,1 Cascapera Stefano,3,4 Carmela Colica5/titolo:A Hydroxytyrosol-Based Pharmaceutical Formulation for the Prevention of Cardiovascular Disease: A Randomized Controlled Crossover Trial/doi:/rivista:Biomedicine & preventive nutrition/anno:2017/pagina_da:62/pagina_a:69/intervallo_pagine:62–69/volume

In 2012 the 63% of worldwide deaths was been due to Non Communicable Diseases (NCDs), mainly cardiovascular disease (CVD), cancer, diabetes and chronic respiratory diseases. WHO projections expect a globally increase of 15% for NCDs deaths between 20

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=cnr_________::f30b696ebc02debdd15df0c73103b5aa
https://publications.cnr.it/doc/386269